Interdisciplinary Team

Deep Genomics has over 100 team members, with expertise in artificial intelligence, automation, cell and molecular biology, clinical development, in vitro disease models, machine learning, medicine, molecular genetics, preclinical development, organic chemistry, and software engineering.
Management Team

Brendan Frey, Ph.D.
Founder and Chief Executive Officer

Walter Strapps
Chief Scientific Officer

David Johnston
Chief Financial Officer

Amit Deshwar, Ph.D.
Senior Vice President and Head of Platform

Hyla Pollak
Vice President of People Operations

Troy Simpson
Vice President and Head of Research Operations

Asha Rostamianfar
Head of Software and Data Engineering
Strategic Advisory Board

Jennifer Cook, M.B.A., M.S.
Strategic Advisor and Special Advisor to the CEO; Board Member, BridgeBio; CEO, Grail; Senior Management, Genentech & Roche

Peter Barton Hutt, L.L.B., L.L.M
Senior Counsel, Covington & Burling, LLP

Steve Jurvetson, M.S.E.E., M.B.A.
Co-Founder, Future Ventures Board Member, SpaceX, Tesla

Vinod Khosla, M.S., M.B.A.
Founder, Khosla Ventures; Co-Founder, Sun Microsystems

Vern Norviel, M.S., J.D.
Partner, Wilson Sonsini Goodrich and Rosati; Adjunct Professor, UC Berkeley

Tal Zaks, M.D., Ph.D.
Venture Partner, Orbimed; Previously Chief Medical Officer at Moderna; Board Member Adaptimmune Therapeutics and Teva Pharmaceutical Industries
Scientific Advisory Board

Art Krieg, M.D.
Former CEO/CSO, Checkmate Pharmaceuticals and Former President, Oligonucleotide Therapeutic Society

Mark Edbrooke, Ph.D.
Former AstraZeneca, GlaxoSmithKline

Masad Damha, Ph.D.
Distinguished James McGill Professor of Chemistry, McGill University

Steven Dowdy, Ph.D.
Professor, University of California San Diego School of Medicine

Yann LeCun Ph.D.
Chief AI Scientist, Facebook; Professor, New York University

Benjamin Neale, Ph.D.
Associate Professor in the Analytic and Translational Genetics Unit, Massachusetts General Hospital
Board of Directors

Brendan Frey, Ph.D.
Board Member

William D. “Chip” Baird, M.B.A.
Lead Independent Director

Adam D'Augelli
Board Member

Maryanna Saenko, M.S.
Board Member

Matt Cahill, J.D., Ph.D., M.B.A.
Board Member

Nessan Bermingham, Ph.D.
Board Member

Jacqueline Fok, Ph.D.
Board Member

Dion Madsen, C.F.A.
Board Observer
Investors







Offices
Deep Genomics has offices in Toronto and Boston. The AI platform and preclinical research teams are located in the heart of Toronto, the fastest growing tech hub in North America and widely recognized as one of the most livable cities in the world. The facilities are located in the MaRS Discovery District, right beside the University of Toronto, four research hospitals, three medical research institutes, and the AI research labs of Google, Uber and the Vector Institute for Artificial Intelligence. The clinical development and business development teams are led out of Boston.